LWANC
HQL

Laurel Wealth Advisors (North Carolina)’s abrdn Life Sciences Investors HQL Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-65
Closed -$1K – 570
2022
Q2 		$1K Hold
65
– – ﹤0.01% 590
2022
Q1 		$1K Hold
65
– – ﹤0.01% 631
2021
Q4 		$1K Hold
65
– – ﹤0.01% 632
2021
Q3 		$1K Hold
65
– – ﹤0.01% 642
2021
Q2 		$1K Sell
65
-113
-63% -$2.28K ﹤0.01% 720
2021
Q1 		$4K Buy
+178
New +$3.67K ﹤0.01% 528

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
CA
Cornerstone Advisors Asheville, North Carolina $2.72B AUM 22.17% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s HQL Position: Q3 2022 in Review

Laurel Wealth Advisors (North Carolina) sold out of abrdn Life Sciences Investors (HQL) in Q3 2022, closing a stake of 65 shares — an estimated $1K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in HQL in Q1 2021 and held it in 6 quarters. The position peaked at $4K in Q1 2021. 63 funds tracked by Wall St. Rank hold HQL as of Q3 2022.

  • Laurel Wealth Advisors (North Carolina) reported no remaining abrdn Life Sciences Investors position as of Q3 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 65 abrdn Life Sciences Investors shares in Q3 2022, an estimated $1K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in abrdn Life Sciences Investors in Q1 2021 and held it in 6 quarters.
  • Laurel Wealth Advisors (North Carolina)'s abrdn Life Sciences Investors position peaked at $4K in Q1 2021.
  • 63 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2022.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q3 2022, filed 15 Nov 2022.